BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6744857)

  • 1. Anaemia and menstrual blood loss studies in women using multiload Cu250 and progestasert IUDs.
    Goh TH; Hariharan M; Chan GL
    Contraception; 1984 Apr; 29(4):359-66. PubMed ID: 6744857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of laparoscopic sterilization and insertion of Multiload Cu 250 and Progestasert IUDs on serum ferritin levels.
    Goh TH; Hariharan M
    Contraception; 1983 Oct; 28(4):329-36. PubMed ID: 6667621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual blood loss, haemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu 200, and TCu 220c IUDs.
    Gao J; Zeng S; Sun BL; Wu SC; Dong J; Cong J; Zhu XH; Fan HM; Han LH; Xie Z
    Contraception; 1986 Dec; 34(6):559-71. PubMed ID: 3829674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative studies on menstrual blood loss in IUD users.
    Andrade AT; Pizarro Orchard E
    Contraception; 1987 Jul; 36(1):129-44. PubMed ID: 3311622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of copper surface area on menstrual blood loss and iron status in women fitted with an IUD.
    Milsom I; Rybo G; Lindstedt G
    Contraception; 1990 Mar; 41(3):271-81. PubMed ID: 2323218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Menstrual blood loss and body iron stores: comparative study between a Multiload-375 IUD and a levonorgestrel vaginal ring].
    Souza JP; Andrade AT; Pizarro E
    Bol Cent Biol Reprod; 1991; 10(1):26-32. PubMed ID: 12318141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study of serum iron indices and haemoglobin concentration following copper-IUD insertion.
    Goh TH; Hariharan M; Tan CH
    Contraception; 1980 Oct; 22(4):389-95. PubMed ID: 7449387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status.
    Milsom I; Andersson K; Jonasson K; Lindstedt G; Rybo G
    Contraception; 1995 Sep; 52(3):175-9. PubMed ID: 7587189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
    Andrade AT; de Souza JP; Rowe PJ; Shaw ST
    Contraception; 1979 Jul; 20(1):19-26. PubMed ID: 477314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term effects of copper surface area on menstrual blood loss and iron status in women fitted with an IUD.
    Larsson G; Milsom I; Jonasson K; Lindstedt G; Rybo G
    Contraception; 1993 Nov; 48(5):471-80. PubMed ID: 8275696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menstrual blood loss, iron nutriture, and the effects of Alza-T IPCS 52, T-Cu 220C and Lippes Loop D in Korean women.
    Tchai BS; Kim SW; Han JH; Im MW
    Seoul J Med; 1987 Jun; 28(2):51-9. PubMed ID: 12283693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical study comparing the performance of three IUCDs (Multiload Copper 250, Copper T 200, and Lippes Loop C).
    Fakhr MM; Fakhr DM; Hassan AA; Nasser NM
    Popul Sci; 1988; 8():39-53. PubMed ID: 12316112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cortisol level in lactating women using Progestasert system.
    Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
    Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
    Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of uterine blood loss caused by various intrauterine contraceptive devices in South American women. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction.
    Andrade AT; Pizarro E; Shaw ST; Souza JP; Belsey EM; Rowe PJ
    Contraception; 1988 Jul; 38(1):1-18. PubMed ID: 3048870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual blood loss of TCu-380 A and TCu-200 B IUDs.
    El-sheikha Z; Hamza A; Mahmoud M
    Popul Sci; 1990 Jul; ():55-62. PubMed ID: 12343358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.